Titre : Benzofuranes

Benzofuranes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Refractive Errors
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Benzofuranes : Questions médicales les plus fréquentes", "headline": "Benzofuranes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Benzofuranes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-05", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Benzofuranes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés hétérobicycliques", "url": "https://questionsmedicales.fr/mesh/D006574", "about": { "@type": "MedicalCondition", "name": "Composés hétérobicycliques", "code": { "@type": "MedicalCode", "code": "D006574", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Amiodarone", "alternateName": "Amiodarone", "url": "https://questionsmedicales.fr/mesh/D000638", "about": { "@type": "MedicalCondition", "name": "Amiodarone", "code": { "@type": "MedicalCode", "code": "D000638", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.075" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dronédarone", "alternateName": "Dronedarone", "url": "https://questionsmedicales.fr/mesh/D000077764", "about": { "@type": "MedicalCondition", "name": "Dronédarone", "code": { "@type": "MedicalCode", "code": "D000077764", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.075.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Benzbromarone", "alternateName": "Benzbromarone", "url": "https://questionsmedicales.fr/mesh/D001553", "about": { "@type": "MedicalCondition", "name": "Benzbromarone", "code": { "@type": "MedicalCode", "code": "D001553", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.110" } } }, { "@type": "MedicalWebPage", "name": "Cantharidine", "alternateName": "Cantharidin", "url": "https://questionsmedicales.fr/mesh/D002193", "about": { "@type": "MedicalCondition", "name": "Cantharidine", "code": { "@type": "MedicalCode", "code": "D002193", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.125" } } }, { "@type": "MedicalWebPage", "name": "Citalopram", "alternateName": "Citalopram", "url": "https://questionsmedicales.fr/mesh/D015283", "about": { "@type": "MedicalCondition", "name": "Citalopram", "code": { "@type": "MedicalCode", "code": "D015283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.187" } } }, { "@type": "MedicalWebPage", "name": "Escitalopram", "alternateName": "Escitalopram", "url": "https://questionsmedicales.fr/mesh/D000089983", "about": { "@type": "MedicalCondition", "name": "Escitalopram", "code": { "@type": "MedicalCode", "code": "D000089983", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.203" } } }, { "@type": "MedicalWebPage", "name": "Fura-2", "alternateName": "Fura-2", "url": "https://questionsmedicales.fr/mesh/D016257", "about": { "@type": "MedicalCondition", "name": "Fura-2", "code": { "@type": "MedicalCode", "code": "D016257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.250" } } }, { "@type": "MedicalWebPage", "name": "Griséofulvine", "alternateName": "Griseofulvin", "url": "https://questionsmedicales.fr/mesh/D006118", "about": { "@type": "MedicalCondition", "name": "Griséofulvine", "code": { "@type": "MedicalCode", "code": "D006118", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.275" } } } ], "about": { "@type": "MedicalCondition", "name": "Benzofuranes", "alternateName": "Benzofurans", "code": { "@type": "MedicalCode", "code": "D001572", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Zhi Xu", "url": "https://questionsmedicales.fr/author/Zhi%20Xu", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China." } }, { "@type": "Person", "name": "Wei Zhou", "url": "https://questionsmedicales.fr/author/Wei%20Zhou", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China." } }, { "@type": "Person", "name": "Ashraf A Abbas", "url": "https://questionsmedicales.fr/author/Ashraf%20A%20Abbas", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602." } }, { "@type": "Person", "name": "Kamal M Dawood", "url": "https://questionsmedicales.fr/author/Kamal%20M%20Dawood", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602." } }, { "@type": "Person", "name": "Giovanni Luca Beretta", "url": "https://questionsmedicales.fr/author/Giovanni%20Luca%20Beretta", "affiliation": { "@type": "Organization", "name": "Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Improving population-level refractive error monitoring via mixture distributions.", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/36751103", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/opo.13105" } }, { "@type": "ScholarlyArticle", "name": "Factors contributing to long-term refractive error after cataract surgery.", "datePublished": "2023-01-02", "url": "https://questionsmedicales.fr/article/36592262", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10792-022-02630-w" } }, { "@type": "ScholarlyArticle", "name": "Deep learning for predicting refractive error from multiple photorefraction images.", "datePublished": "2022-08-08", "url": "https://questionsmedicales.fr/article/35941613", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12938-022-01025-3" } }, { "@type": "ScholarlyArticle", "name": "Utility for Uncorrected Refractive Errors in Adolescent Schoolchildren in Kakamega County, Kenya.", "datePublished": "2023-08-15", "url": "https://questionsmedicales.fr/article/37585852", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/OPX.0000000000002054" } }, { "@type": "ScholarlyArticle", "name": "High prevalence of refractive errors in an elderly population; a public health issue.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/36707798", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12886-023-02791-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzofuranes", "item": "https://questionsmedicales.fr/mesh/D001572" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Benzofuranes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Benzofuranes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Benzofuranes", "description": "Comment diagnostiquer une intoxication aux benzofuranes ?\nQuels tests sont utilisés pour détecter les benzofuranes ?\nQuels symptômes indiquent une exposition aux benzofuranes ?\nLes benzofuranes sont-ils visibles sur des tests standards ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Refractive+Errors&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Benzofuranes", "description": "Quels sont les symptômes courants des benzofuranes ?\nLes benzofuranes provoquent-ils des effets psychologiques ?\nY a-t-il des symptômes cutanés associés aux benzofuranes ?\nLes benzofuranes affectent-ils le système respiratoire ?\nLes symptômes varient-ils selon la dose de benzofuranes ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Refractive+Errors&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Benzofuranes", "description": "Comment prévenir l'exposition aux benzofuranes ?\nLes travailleurs doivent-ils être formés sur les benzofuranes ?\nQuelles mesures de sécurité sont recommandées en laboratoire ?\nLes benzofuranes sont-ils réglementés ?\nComment gérer les déchets contenant des benzofuranes ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Refractive+Errors&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Benzofuranes", "description": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?\nDes antidotes existent-ils pour les benzofuranes ?\nComment traiter les symptômes neurologiques causés par les benzofuranes ?\nLes soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?\nLa décontamination est-elle nécessaire après exposition ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Refractive+Errors&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Benzofuranes", "description": "Quelles complications peuvent survenir après exposition aux benzofuranes ?\nLes benzofuranes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des benzofuranes ?\nLes benzofuranes peuvent-ils affecter la reproduction ?\nComment surveiller les complications liées aux benzofuranes ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Refractive+Errors&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Benzofuranes", "description": "Qui est à risque d'exposition aux benzofuranes ?\nLes benzofuranes sont-ils présents dans des produits courants ?\nL'âge influence-t-il la sensibilité aux benzofuranes ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes benzofuranes affectent-ils différemment les sexes ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Refractive+Errors&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux benzofuranes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et les tests toxicologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les benzofuranes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux benzofuranes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des nausées et des palpitations." } }, { "@type": "Question", "name": "Les benzofuranes sont-ils visibles sur des tests standards ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, des tests spécifiques sont nécessaires pour détecter les benzofuranes." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux benzofuranes." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des benzofuranes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des vertiges, des maux de tête et des troubles de la vision." } }, { "@type": "Question", "name": "Les benzofuranes provoquent-ils des effets psychologiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent causer de l'anxiété, des hallucinations et des troubles de l'humeur." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés associés aux benzofuranes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées et des démangeaisons peuvent survenir après exposition." } }, { "@type": "Question", "name": "Les benzofuranes affectent-ils le système respiratoire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent provoquer des difficultés respiratoires et une irritation des voies respiratoires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose de benzofuranes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux benzofuranes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés sur les benzofuranes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle." } }, { "@type": "Question", "name": "Quelles mesures de sécurité sont recommandées en laboratoire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des hottes, des gants et des lunettes de protection lors de la manipulation." } }, { "@type": "Question", "name": "Les benzofuranes sont-ils réglementés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur utilisation est souvent réglementée en raison de leur toxicité potentielle." } }, { "@type": "Question", "name": "Comment gérer les déchets contenant des benzofuranes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les déchets doivent être éliminés selon les protocoles de gestion des déchets dangereux." } }, { "@type": "Question", "name": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement comprend l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les benzofuranes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antidote spécifique pour les benzofuranes." } }, { "@type": "Question", "name": "Comment traiter les symptômes neurologiques causés par les benzofuranes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour gérer les symptômes neurologiques." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins d'urgence peuvent être nécessaires en cas d'exposition sévère." } }, { "@type": "Question", "name": "La décontamination est-elle nécessaire après exposition ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la décontamination est essentielle pour réduire l'absorption des benzofuranes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition aux benzofuranes ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, respiratoires et dermatologiques peuvent survenir." } }, { "@type": "Question", "name": "Les benzofuranes peuvent-ils causer des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut augmenter le risque de maladies chroniques." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme des benzofuranes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes respiratoires." } }, { "@type": "Question", "name": "Les benzofuranes peuvent-ils affecter la reproduction ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction." } }, { "@type": "Question", "name": "Comment surveiller les complications liées aux benzofuranes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier est recommandé pour détecter les complications précoces." } }, { "@type": "Question", "name": "Qui est à risque d'exposition aux benzofuranes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque." } }, { "@type": "Question", "name": "Les benzofuranes sont-ils présents dans des produits courants ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être présents dans certains produits chimiques et médicaments." } }, { "@type": "Question", "name": "L'âge influence-t-il la sensibilité aux benzofuranes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles." } }, { "@type": "Question", "name": "Les antécédents médicaux augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies respiratoires ou neurologiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les benzofuranes affectent-ils différemment les sexes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent que les effets peuvent varier entre les sexes, mais les données sont limitées." } } ] } ] }

Sources (4266 au total)

Improving population-level refractive error monitoring via mixture distributions.

Sampling and describing the distribution of refractive error in populations is critical to understanding eye care needs, refractive differences between groups and factors affecting refractive developm... We used key informants to identify raw refractive error datasets and a systematic search strategy to identify published binned datasets of community-representative refractive error. Mixture models com... We obtained large raw refractive error datasets from the United States and Korea. The ability of our models to fit the data improved significantly from a single-Gaussian to a two-Gaussian-component ad... Mixture models appear able to describe the population distribution of refractive error accurately, offering significant advantages over commonly quoted simple summary statistics such as mean, standard...

Factors contributing to long-term refractive error after cataract surgery.

To evaluate factors that may influence the direction and extent of long-term refractive error after cataract surgery.... This was a retrospective observational study conducted across two private practices in Sydney, NSW, Australia. The study population consisted of patients who underwent cataract phacoemulsification sur... This study included 221 eyes of 122 patients. A refractive error within 1.00 D was achieved in 217 eyes (98.2%) at 3 years post-operatively. Mean prediction error decreased significantly between 2 mon... After cataract surgery, refractive outcomes may be influenced by ACD and ACD-to-AL ratio. The pre-operative assessment of these risk factors may better inform IOL selection in individual patients. Pro...

Deep learning for predicting refractive error from multiple photorefraction images.

Refractive error detection is a significant factor in preventing the development of myopia. To improve the efficiency and accuracy of refractive error detection, a refractive error detection network (... The results show that the mean absolute error (MAE) values of the spherical power, cylindrical power, and spherical equivalent can reach 0.1740 D (diopters), 0.0702 D, and 0.1835 D, respectively.... This method demonstrates a much higher accuracy than those of current state-of-the-art deep-learning methods. Moreover, it is effective and practical....

Utility for Uncorrected Refractive Errors in Adolescent Schoolchildren in Kakamega County, Kenya.

Uncorrected refractive errors (UREs) present an enormous lifetime burden in children. Despite this, there is a dearth of knowledge on URE-related preference-based quality of life (QoL) in East Africa.... This study investigated the preference-based QoL (utility) for URE in school-going adolescents of Kakamega County, in Kenya.... An observational cross-sectional study with multistage sampling was conducted on randomly selected secondary school adolescents. School-going adolescents in Forms 1 to 4 were clinically examined for t... A total of 330 participants aged 17.32 ± 1.60 years (URE, 17.50 ± 1.58 years; normal-sight, 17.15 ± 1.61 years) were included in the study. The mean utility score, as elicited by the Assessment of Qua... Uncorrected refractive errors are associated with reduced utility in school-going adolescents, regardless of URE subtype. Spectacle correction resulted in a significantly improved utility for those wi...

High prevalence of refractive errors in an elderly population; a public health issue.

To determine the prevalence of myopia and hyperopia and their associated demographic and ocular factors in people 60 years of age and above.... The sampling was performed using a multi-stage stratified random cluster sampling method. The complete demographic and case history information were collected through an interview. Then, all participa... Three thousand three hundred ten of 3791 invitees participated, and the data of 3263 individuals were analyzed for this report. The mean age of participants was 68.25 ± 6.53 (60 to 97) years, and 1895... The prevalence of refractive errors was high in the Iranian elderly population. A large percentage of the elderly still did not have complete visual acuity after the correction of refractive errors in...

Comparison of the new self-contained darkroom refractive screener versus table-top autorefractor and cycloplegia retinoscopy in detecting refractive error.

By comparing the results of the new self-contained darkroom refractive screener (YD-SX-A) versus table-top autorefractor and cycloplegic retinoscopy, to evaluate the performance of the YD-SX-A in dete... Cross-sectional study. 1000 participants between the ages of 6 and 18 who visited the Optometry Center of the People's Hospital of Guangxi Zhuang Autonomous Region from June to December 2022 were sele... The average age of participants was 10.77 ± 3.00 years, including 504 boys (50.4%) and 496 girls (49.6%). When YD-SX-A and cycloplegia retinoscopy (CR) were compared in the myopia group, there was no ... This study has identified that YD-SX-A has shown good performance in both agreement and effectiveness in detecting refractive error when compared with Topcon KR8800 and CR. YD-SX-A could be a useful t...

Corneal higher order aberrations by Sirius topography and their relation to different refractive errors.

To compare the root mean square (RMS) of anterior corneal higher-order aberrations (HOAs) in ametropic and emmetropic eyes.... This retrospective observational study was conducted at the Department of Ophthalmology, Tishreen University Hospital, Latakia, Syria. Study eyes were divided into four groups based on refractive erro... RMS values of total HOAs, trefoil and coma showed statistically significant differences in all four groups (P < 0.05, all). HOAs were noted to be lowest in the control group (0.18 ± 0.09, 011 ± 0.08 a... The mean RMS values of total HOAs, trefoil and coma were highest in the astigmatism group and lowest in the control group. However, spherical aberration was minimal in the astigmatism group. A better ...

Association analyses of rare variants identify two genes associated with refractive error.

Genetic variants identified through population-based genome-wide studies are generally of high frequency, exerting their action in the central part of the refractive error spectrum. However, the power... Genetic association analyses of non-cyclopaedic autorefraction calculated as mean spherical equivalent (SPHE) used whole-exome sequence genotypic information from 50,893 unrelated participants in the ... We found strong statistical evidence for association of SPHE with the SIX6 (p-value = 2.15 x 10-10, or Bonferroni-Corrected p = 4.41x10-06) and the CRX gene (p-value = 6.65 x 10-08, or Bonferroni-Corr... The results of our study support previous research highlighting the importance of rare variants to the genetic risk of refractive error. We explain some of the origins of the genetic signals seen in G...

Refractive errors and ocular findings in children and adolescents with mental disorders: a retrospective study.

An increasing prevalence of mental disorders (MDs) has been reported among children and adolescents. However, only few studies have conducted ocular examinations, including those on refractive status,... A total of 178 participants with MDs and 200 controls were recruited between April 2021 and May 2022. All the children and adolescents underwent cycloplegic or noncycloplegic autorefraction and retino... Twenty-seven percent of patients with MDs and 8% of controls had ocular findings, the most common of which were conjunctivitis, keratitis, and trichiasis. For refractive status, 70% (124/178) of patie... Ophthalmological examinations should be performed in children and adolescents with MDs because MDs are associated with a high prevalence of refractive errors and ocular diseases. Detection and interve...

Comparison of Three Different Devices for the Evaluation of Axial Length, Refractive Error, and Keratometry.

Myopia prevalence is increasing worldwide. Axial length, refractive error, and keratometry are important outcome measures in myopia management. Precise measurement methods are required for myopia mana... The aim of this study was to compare three different devices to evaluate axial length, refractive error, and keratometry.... A total of 120 subjects (37.7 ± 15.5 years) were enrolled in this prospective study. All subjects were measured with DNEye Scanner 2 (Rodenstock GmbH, Munich, Germany), Myopia Master (Oculus Optikgerä... Differences for axial length were as follows: DNEye Scanner 2 versus Myopia Master, 0.67 ± 0.46 mm; DNEye Scanner 2 versus IOLMaster 700, 0.64 ± 0.46 mm; and Myopia Master versus IOLMaster 700, -0.02 ... The results for axial length and keratometry from Myopia Master and IOLMaster were comparable. The axial length calculated by DNEye Scanner 2 was significantly different from interferometry devices an...